About Clínica de Nefrología, Urología y Enfermedades Cardiovasculares
"Grupo Nefro. Clínica de Nefrología. Sanatorio Líder y referente en la Región en Trasplantes de Órganos y las Prácticas de Alta Complejidad. Diagnóstico y Tratamiento Médico. Excelencia profesional, capacitación y formación médica continua."
Clinical Trials at Clínica de Nefrología, Urología y Enfermedades Cardiovasculares
During the past decade, Clínica de Nefrología, Urología y Enfermedades Cardiovasculares conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Clínica de Nefrología, Urología y Enfermedades Cardiovasculares"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Clínica de Nefrología, Urología y Enfermedades Cardiovasculares
According to Clinical.Site data, the most researched conditions in "Clínica de Nefrología, Urología y Enfermedades Cardiovasculares" are
"Chronic Lymphocytic Leukemia" (1 trials), "Heart Failure" (1 trials), "Heart Failure With Preserved Ejection Fraction" (1 trials), "Leukemia, B-cell" (1 trials) and "Leukemia, Lymphocytic" (1 trials). Many other conditions were trialed in "Clínica de Nefrología, Urología y Enfermedades Cardiovasculares" in a lesser frequency.
Clinical Trials Intervention Types at Clínica de Nefrología, Urología y Enfermedades Cardiovasculares
Most popular intervention types in "Clínica de Nefrología, Urología y Enfermedades Cardiovasculares" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Ibrutinib" (1 trials), "LY3540378" (1 trials), "Pirtobrutinib" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Clínica de Nefrología, Urología y Enfermedades Cardiovasculares
The vast majority of trials in "Clínica de Nefrología, Urología y Enfermedades Cardiovasculares" are
2 trials for "All" genders.
Clinical Trials Status at Clínica de Nefrología, Urología y Enfermedades Cardiovasculares
Currently, there are NaN active trials in "Clínica de Nefrología, Urología y Enfermedades Cardiovasculares".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Clínica de Nefrología, Urología y Enfermedades Cardiovasculares,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Clínica de Nefrología, Urología y Enfermedades Cardiovasculares, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".